The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 24, 2024
Filed:
Nov. 22, 2023
Applicant:
Lipocine Inc., Salt Lake City, UT (US);
Inventors:
Mahesh V. Patel, Salt Lake City, UT (US);
Nachiappan Chidambaram, Salt Lake City, UT (US);
Satish Kumar Nachaegari, Salt Lake City, UT (US);
Srinivasan Venkateshwaran, Salt Lake City, UT (US);
Joel Frank, Salt Lake City, UT (US);
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/568 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/568 (2013.01); A61K 9/0053 (2013.01); A61K 9/16 (2013.01); A61K 39/00 (2013.01);
Abstract
Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one. Pharmaceutical compositions and the dosage forms of the bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters can be used to treat any condition associated with testosterone deficiency, including complete absence of endogenous testosterone in male or female subjects.